Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacterial Infections

Characterization of the Mode of Action of Aurodox, a Type III Secretion System Inhibitor from Streptomyces goldiniensis

Rebecca E. McHugh, Nicky O’Boyle, James P. R. Connolly, Paul A. Hoskisson, Andrew J. Roe
Andreas J. Bäumler, Editor
Rebecca E. McHugh
aInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom
bStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicky O’Boyle
aInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James P. R. Connolly
aInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul A. Hoskisson
bStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paul A. Hoskisson
Andrew J. Roe
aInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew J. Roe
Andreas J. Bäumler
University of California, Davis
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.00595-18
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • FIG 1
    • Open in new tab
    • Download powerpoint
    FIG 1

    Aurodox inhibits secretion of T3SS-associated effector proteins in EPEC, EHEC, and Citrobacter rodentium without affecting bacterial growth. (A) Secreted protein fractions were prepared by culturing strains in T3S-inducing medium and precipitated from the supernatant using trichloroacetic acid. Whole-cell fractions were prepared by lysis of cell pellets. Samples were resolved using SDS-gel electrophoresis followed by Coomassie staining. Marked protein bands were excised and trypsin digested for mass spectrometry identification of proteins. (B) Aurodox does not inhibit the growth of EPEC, EHEC, or C. rodentium in T3S-inducing medium. EHEC was grown in MEM-HEPES, and EPEC and C. rodentium were grown in DMEM. Growth rates were determined spectrophotometrically (OD600; n = 3). Error bars plotted are SDs. Changes in growth were not statistically significant.

  • FIG 2
    • Open in new tab
    • Download powerpoint
    FIG 2

    Effect of Aurodox on EHEC infection of epithelial cells and A/E lesion formation. (A) Representative microscopy images from EHEC cell infection assay. Cells were infected with 107 EHEC cells transformed with prpsM-gfp (green) to facilitate quantification and imaging. HeLa cells were actin stained with phalloidin-Alexa Fluor 555 (red) and mounted in Vectashield with DAPI (blue). Scale bar represents 50 μm. Insets contain a ×4 magnification of the indicated area. (B) Colonization was quantitated by counting the numbers of cells possessing EHEC on their surface and expressing as a percentage of the total. (C) Following infection, HeLa cells were washed to remove nonadherent bacteria and subsequently lysed to release colonized bacteria. The CFU of EHEC in the lysate were enumerated, and colonization efficiency was calculated by expressing as a percentage of the inoculum. Significance was calculated by paired Student’s t test. *, P < 0.05; **, P < 0.01.

  • FIG 3
    • Open in new tab
    • Download powerpoint
    FIG 3

    Transcriptional changes induced by Aurodox in EHEC. (A) Venn diagram representing overlap between genes significantly downregulated by Aurodox (>1.5 fold; P < 0.05) and LEE genes. (B) Heat map representation of log2 fold change in gene expression after treatment with Aurodox. (C) Effect of Aurodox on expression of ler and the housekeeping gene rpsM. Aurodox was added at 5 µg/ml and expression measured after 4 h of growth. Expression of rpsM was not significantly altered in contrast to that of Ler (P = 0.009). Error bars plotted are equivalent to the SDs (n = 3). **, P < 0.005.

  • FIG 4
    • Open in new tab
    • Download powerpoint
    FIG 4

    Transcriptional repression of ler does not occur as a result of the interaction of Aurodox with the T3S needle. (A) Analysis of ler expression in EPEC mutants with deletions of genes encoding structural components of the T3SS. Mutant strains were transformed with pler-gfp. Optical density and fluorescence were measured at hourly intervals and ler expression was quantified as relative fluorescence units (fluorescence/OD600). (B) Relative ler expression during exponential phase in WT EPEC versus EPEC ΔescC treated with Aurodox. Expression of ler in treated samples is expressed as a percentage of untreated samples. (C) Effect of Ler overexpression on the Aurodox phenotype. Arabinose was added to induce expression, and the effect of Aurodox on Tir expression was determined by immunoblotting.

  • FIG 5
    • Open in new tab
    • Download powerpoint
    FIG 5

    Analysis of the effect of Aurodox on RecA-mediated Stx expression. (A) Analysis of in vitro recA-gfp expression in Aurodox-treated EHEC. Aurodox and ciprofloxacin were added at 6 µM. Error bars correspond to SDs (n = 4). P values for Aurodox-treated versus ciprofloxacin-treated bacteria were <0.01. *, P < 0.05; **, P < 0.005; ***, P < 0.001. (B) Immunoblot analysis of Stx expression in untreated, Aurodox-treated, ciprofloxacin-treated, and Aurodox- and ciprofloxacin-treated C. rodentium DBS100. Primary antibodies for Shiga toxin B subunit (6 kDa) were used.

Additional Files

  • Figures
  • Supplemental material

    • Supplemental file 1 -

      Table S1. Strains used in this study. Table S2. Plasmids used in this study. Table S3. MASCOT results for EPEC-secreted protein bands. Table S4. MASCOT results for EHEC-secreted protein bands. Table S5. MASCOT result for C. rodentium-secreted protein bands. Table S6. Chromosomal EHEC TUV93-0 genes downregulated in the presence of aurodox. Table S7. Genes upregulated in the presence of aurodox. Fig. S1. Effect of aurodox on ler expression in EPEC.

      PDF, 243K

PreviousNext
Back to top
Download PDF
Citation Tools
Characterization of the Mode of Action of Aurodox, a Type III Secretion System Inhibitor from Streptomyces goldiniensis
Rebecca E. McHugh, Nicky O’Boyle, James P. R. Connolly, Paul A. Hoskisson, Andrew J. Roe
Infection and Immunity Jan 2019, 87 (2) e00595-18; DOI: 10.1128/IAI.00595-18

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Characterization of the Mode of Action of Aurodox, a Type III Secretion System Inhibitor from Streptomyces goldiniensis
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Characterization of the Mode of Action of Aurodox, a Type III Secretion System Inhibitor from Streptomyces goldiniensis
Rebecca E. McHugh, Nicky O’Boyle, James P. R. Connolly, Paul A. Hoskisson, Andrew J. Roe
Infection and Immunity Jan 2019, 87 (2) e00595-18; DOI: 10.1128/IAI.00595-18
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

bacteria
Escherichia
infection
inhibitor
secretion
virulence

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522